Skip to content

Frequent Facial BBCs Announcement

Ameriderm Research announces beginning December 2019 recruitment for a new clinical trial is for patients 18-75 years of age who have frequent facial Basal Cell Carcinomas (BCCs) but do NOT have Gorlin Syndrome (Basal Cell Carcinoma Nevus Syndrome) The study involves testing a new topical medication to determine its ability to decrease the number of surgical procedures that are needed to treat and control and condition.

The trial is expected to enroll quickly. To see if you qualify please call (386) 523-0768 today.

Join Clinical Trial

Posted in